AE Wealth Management
JAZZ icon

AE Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

AE Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$912K Buy
3,938
+754
+24% +$186K ﹤0.01% 980
2026
Q2 		$767K Buy
3,184
+84
+3% +$18.4K ﹤0.01% 1020
2026
Q1 		$586K Buy
3,100
+369
+14% +$64.5K ﹤0.01% 1027
2025
Q4 		$464K Buy
2,731
+64
+2% +$9.8K ﹤0.01% 1087
2025
Q3 		$352K Buy
2,667
+162
+6% +$19.4K ﹤0.01% 1115
2025
Q2 		$266K Sell
2,505
-25
-1% -$2.72K ﹤0.01% 1162
2025
Q1 		$314K Sell
2,530
-763
-23% -$100K ﹤0.01% 1067
2024
Q4 		$406K Buy
3,293
+698
+27% +$82.3K ﹤0.01% 975
2024
Q3 		$289K Buy
2,595
+62
+2% +$6.79K ﹤0.01% 1043
2024
Q2 		$270K Buy
+2,533
New +$278K ﹤0.01% 1064
2020
Q4 		– Sell
-3,871
Closed -$552K – 1391
2020
Q3 		$552K Buy
+3,871
New +$480K 0.01% 851
2020
Q2 		– Sell
-3,816
Closed -$381K – 1310
2020
Q1 		$381K Buy
+3,816
New +$493K 0.01% 780

Other funds holding JAZZ

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AE Wealth Management's JAZZ Position: Q3 2026 in Review

AE Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q3 2026, buying an estimated $186K and bringing the position to 3,938 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

AE Wealth Management first reported a position in JAZZ in Q1 2020 and has held it in 12 quarters since. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • AE Wealth Management held 3,938 shares of Jazz Pharmaceuticals worth $912K as of Q3 2026.
  • AE Wealth Management bought 754 Jazz Pharmaceuticals shares in Q3 2026, an estimated $186K.
  • Jazz Pharmaceuticals made up ﹤0.01% of AE Wealth Management's portfolio in Q3 2026, its #980 holding.
  • AE Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
  • 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on AE Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.